Arend RC, Beer HM, Cohen YC, Berlin S, et al. Ofranergene obadenovec (VB-111) in platinum-resistant ovarian cancer; favorable response rates in a phase I/II study are associated with an immunotherapeutic effect. Gynecol Oncol 2020 Apr 5. pii: S0090-8258(20)30180.
PMID: 32265057